Description
There is no detailed description, see related
Used in the treatment of
- Y43.1 Adverse effects in therapeutic use, antineoplastic antimetabolites
- Y43.2 Adverse effects in therapeutic use, antineoplastic natural products
- Y43.3 Adverse effects in therapeutic use, other antineoplastic drugs
- Y43.4 Adverse effects in therapeutic use, immunosuppressive agents
- Y84.2 Abnormal reaction/later complication, radiological procedure and radiotherapy
- Z51.0 Radiotherapy session
- Z51.1 Chemotherapy session for neoplasm
- Z54 Convalescence
- Z58.4 Exposure to radiation
- Z98.8 Other specified postsurgical states
- Z100* CHAPTER XXII Surgical practice
- F10.3 Mental and behavioural disorders due to use of alcohol, withdrawal state
- K21 Gastro-oesophageal reflux disease
- K21.0 Gastro-oesophageal reflux disease with oesophagitis
- K25 Gastric ulcer
- K26 Duodenal ulcer
- K29.1 Other acute gastritis
- K29.5 Chronic gastritis, unspecified
- K91.3 Postoperative intestinal obstruction
- K94* Diagnosis of gastrointestinal diseases
- R11 Nausea and vomiting
- T51 Toxic effect of alcohol
- T66 Unspecified effects of radiation
- T90.5 Sequelae of intracranial injury